Completed from United Kingdom
I signed up for the advanced pharma econ certificate because I wanted to get a better grip on pricing strategies, and it totally delivered. The video lessons on value‑based pricing were easy to follow, and the group project where we built a mock pricing dossier for a new biologic was super useful – I actually used that template in my current job at a pharma startup. The reading list was spot‑on, and the tutor was always quick to answer questions. I'd definitely recommend it to anyone looking to level up their pharma economics game.
The Zertifikat in Pharmazeutischer Gesundheitsökonomie (Advanced) precisely matched my goal of mastering cost‑effectiveness analysis in pharmaceutical policy. The modules on HTA methodology and budget impact modeling gave me hands‑on experience with Excel‑based models that I now use in my role at a health‑technology assessment firm. The case studies from the German market were particularly relevant, and the lecture slides were clear and up‑to‑date. Overall, the program exceeded my expectations and I feel fully equipped to advise senior management on reimbursement strategies.
Wow! This course blew me away! I wanted to understand how health economics can shape policy in India, and the deep dive into cost‑utility analysis gave me the exact tools I needed. I loved the interactive simulations where we calculated QALYs for different treatment scenarios – I even presented one of those analyses at my company’s quarterly meeting and got great feedback. The course materials were beautifully designed, with real‑world examples from both Europe and Asia. I'm thrilled with what I've learned and feel confident to lead new health‑economic projects!
The Zertifikat in Pharmazeutischer Gesundheitsökonomie (Advanced) provided a comprehensive framework that aligned perfectly with my learning objectives of mastering pharmacoeconomic evaluation techniques. Throughout the eight-week program, I engaged with detailed modules covering incremental cost‑effectiveness ratios, sensitivity analysis, and the ethical considerations of resource allocation. The instructor’s supplementary handbooks, which included step‑by‑step Excel templates and recent journal articles, were indispensable for my final capstone project on the affordability of oncology drugs in South Africa. Moreover, the peer‑review sessions allowed me to refine my analytical approach based on diverse perspectives. I rate the course highly for its rigor, relevance, and the practical skill set it imparted.
